Rare diseases
Investigational molecules
Locations
Back to France1 164 clinical trials in Bordeaux, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration
FranceStudy of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back
FranceA study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene
FranceA study of DT-7012 alone and in combination with pembrolizumab in patients with advanced solid tumors
FranceStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
FranceA study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy
FranceA Study to Find a Safe Dose of TD001 for Patients with Metastatic Castration-Resistant Prostate Cancer that Expresses PSMA
FranceA study testing ASP3082 in patients with advanced or spreading non-small cell lung cancer and pancreatic ductal adenocarcinoma
FranceStudy of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy
FranceA study testing sonlicromanol in adults with genetically confirmed mitochondrial DNA 3243A>G variant causing mitochondrial disease
FranceA Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa
FranceStudy of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and hidradenitis suppurativa, evaluating new therapeutic combinations and treatment strategies. Studies explore the effectiveness of targeted therapies and novel approaches like fecal microbiota transplantation.
Clinical trials aim to improve patient outcomes through combination therapies and innovative treatment approaches.
Comprehensive studies investigating treatments for various cancers, including head and neck squamous cell carcinoma, endometrial cancer, and bladder cancer. Research focuses on immunotherapy combinations and targeted treatments.
Trials evaluate novel drug combinations and therapeutic approaches for better cancer treatment outcomes.
Ground-breaking research in kidney transplantation, focusing on preventing rejection and improving long-term outcomes. Studies evaluate new immunosuppressive strategies and antibody-mediated rejection treatments.
Research aims to enhance transplant success rates and patient quality of life.
Studies examining multiple sclerosis, narcolepsy, and major depressive disorder. Research investigates neuroinflammation patterns and innovative treatment approaches.
Trials focus on understanding disease mechanisms and developing targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
